Targeting group II Metabotropic Glutamate (mGlu) receptors for the treatment of psychosis associated with alzheimer's disease: Selective activation of mGlu2 receptors amplifies β-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective

Filippo Caraci, Gemma Molinaro, Giuseppe Battaglia, Maria Laura Giuffrida, Barbara Riozzi, Anna Traficante, Valeria Bruno, Milena Cannella, Sara Merlo, Xushan Wang, Beverly A. Heinz, Eric S. Nisenbaum, Thomas C. Britton, Filippo Drago, Maria Angela Sortino, Agata Copani, Ferdinando Nicoletti

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Targeting group II Metabotropic Glutamate (mGlu) receptors for the treatment of psychosis associated with alzheimer's disease: Selective activation of mGlu2 receptors amplifies β-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective'. Together they form a unique fingerprint.

Medicine & Life Sciences